4D Path vs ImmunoScape
4D Path vs ImmunoScape, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 4D Path is on 59/100 and ImmunoScape on 58/100.
Where each one leads
4D Path
Leads on none of the measures we hold for both companies.
ImmunoScape
- agent readiness: 39/100 against 30/100
- domain rating: 28/100 against 9/100
- funding raised: $49.7M against $17.4M
- LinkedIn following: 4,364 against 1,262
At a glance
| Measure | 4D Path | ImmunoScape |
|---|---|---|
| What it is | Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy. | Developing novel immunotherapies and diagnostics for cancer. |
| Category | Biotechnology, HealthTech, Artificial Intelligence, Cancer Research | Biotechnology, Cancer, Immunotherapy, Diagnostics |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Platform | Platform |
| Founded | 2016 | 2017 |
| Headquarters | Newton, USA | Singapore, Singapore |
| Status | Active | Active |
Size, funding and growth
| Measure | 4D Path | ImmunoScape |
|---|---|---|
| Employees | 17 | Not published |
| Total funding | $17.4M | $49.7M |
| Latest round | Strategic financing | Series B2 |
| Valuation | $1.1B | $1.1B |
| LinkedIn followers | 1,262 | 4,364 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | 4D Path | ImmunoScape |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 58/100 |
| Traction | 49/100 | 38/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 39/100 | 23/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 9/100 | 28/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | 4D Path | ImmunoScape |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Not detected | Google Tag Manager |
What users say
| Measure | 4D Path | ImmunoScape |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 6 positive, 0 negative across 6 threads |
“Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.”r/Quantisnow
4D Path vs ImmunoScape: common questions
Which is better, 4D Path or ImmunoScape?
On our 0-100 score 4D Path rates higher (59/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do 4D Path and ImmunoScape compare on the numbers?
ImmunoScape leads on agent readiness (39/100 against 30/100), domain rating (28/100 against 9/100), funding raised ($49.7M against $17.4M), LinkedIn following (4,364 against 1,262).
What do real users say about 4D Path and ImmunoScape?
ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.
Read the full 4D Path review and pricing or the ImmunoScape review and pricing. You can also browse other 4D Path alternatives we track.